diabetes insipidus

Literature (7)

Literature for DOID 9409: diabetes insipidus

Xenbase Articles Publications associated with this Disease Ontology entry or its descendants

:
(

Denotes literature images)

Evidence for stabilization of aquaporin-2 folding mutants by N-linked glycosylation in endoplasmic reticulum., Buck TM,Eledge J,Skach WR, Am J Physiol Cell Physiol. November 1, 2004; 287(5):1522-1563.
Reversed polarized delivery of an aquaporin-2 mutant causes dominant nephrogenic diabetes insipidus., Kamsteeg EJ,Bichet DG,Konings IB,Nivet H,Lonergan M,Arthus MF,van Os CH,Deen PM, J Cell Biol. December 8, 2003; 163(5):1540-8140.
Two novel aquaporin-2 mutations responsible for congenital nephrogenic diabetes insipidus in Chinese families., Lin SH,Bichet DG,Sasaki S,Kuwahara M,Arthus MF,Lonergan M,Lin YF, J Clin Endocrinol Metab. June 1, 2002; 87(6):0021-972X.
Water transport across mammalian cell membranes., Verkman AS,van Hoek AN,Ma T,Frigeri A,Skach WR,Mitra A,Tamarappoo BK,Farinas J, Am J Physiol. January 1, 1996; 270(1 Pt 1):0002-9513.
Novel treatment for lithium-induced nephrogenic diabetes insipidus rat model using the Sendai-virus vector carrying aquaporin 2 gene., Suga H,Nagasaki H,Kondo TA,Okajima Y,Suzuki C,Ozaki N,Arima H,Yamamoto T,Ozaki N,Akai M,Sato A,Uozumi N,Inoue M,Hasegawa M,Oiso Y, Endocrinology. November 1, 2008; 149(11):1945-7170.
Functional Recovery of AQP2 Recessive Mutations Through Hetero-Oligomerization with Wild-Type Counterpart., El Tarazi A,Lussier Y,Da Cal S,Bissonnette P,Bichet DG, Sci Rep. September 19, 2016; 6:2045-2322.
Molecular characterization of an aquaporin-2 mutation causing a severe form of nephrogenic diabetes insipidus., Saglar Ozer E,Moeller HB,Karaduman T,Fenton RA,Mergen H, Cell Mol Life Sci. March 1, 2020; 77(5):1420-9071.

Evidence for stabilization of aquaporin-2 folding mutants by N-linked glycosylation in endoplasmic reticulum., Buck TM,Eledge J,Skach WR, Am J Physiol Cell Physiol. November 1, 2004; 287(5):1522-1563.

Reversed polarized delivery of an aquaporin-2 mutant causes dominant nephrogenic diabetes insipidus., Kamsteeg EJ,Bichet DG,Konings IB,Nivet H,Lonergan M,Arthus MF,van Os CH,Deen PM, J Cell Biol. December 8, 2003; 163(5):1540-8140.

Two novel aquaporin-2 mutations responsible for congenital nephrogenic diabetes insipidus in Chinese families., Lin SH,Bichet DG,Sasaki S,Kuwahara M,Arthus MF,Lonergan M,Lin YF, J Clin Endocrinol Metab. June 1, 2002; 87(6):0021-972X.

Water transport across mammalian cell membranes., Verkman AS,van Hoek AN,Ma T,Frigeri A,Skach WR,Mitra A,Tamarappoo BK,Farinas J, Am J Physiol. January 1, 1996; 270(1 Pt 1):0002-9513.

Novel treatment for lithium-induced nephrogenic diabetes insipidus rat model using the Sendai-virus vector carrying aquaporin 2 gene., Suga H,Nagasaki H,Kondo TA,Okajima Y,Suzuki C,Ozaki N,Arima H,Yamamoto T,Ozaki N,Akai M,Sato A,Uozumi N,Inoue M,Hasegawa M,Oiso Y, Endocrinology. November 1, 2008; 149(11):1945-7170.

Functional Recovery of AQP2 Recessive Mutations Through Hetero-Oligomerization with Wild-Type Counterpart., El Tarazi A,Lussier Y,Da Cal S,Bissonnette P,Bichet DG, Sci Rep. September 19, 2016; 6:2045-2322.

Molecular characterization of an aquaporin-2 mutation causing a severe form of nephrogenic diabetes insipidus., Saglar Ozer E,Moeller HB,Karaduman T,Fenton RA,Mergen H, Cell Mol Life Sci. March 1, 2020; 77(5):1420-9071.